$CCO

MARCHESE JOE sold (to issuer) $2.2M of CCO

MARCHESE JOE sold (to issuer) 906,807 shares of Clear Channel Outdoor Holdings, Inc. (CCO) at $2.43 ($2.20M total) on 2026-10-14.

Original reporting
SEC EDGAR · MARCHESE JOE
Published Oct 15, 2026, 7:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 15, 2026, 7:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CCO
Neutral
medium confidence
Mentioned
$CCO
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CCONeutralLow
01

Why it matters

The disclosure provides incremental sentiment information but does not include any company-specific fundamental update (no earnings, guidance, contract, or regulatory action).

02

Market read

Traders may briefly monitor for insider selling signals, but the event is unlikely to drive a sustained repricing without additional catalysts.

03

What to watch

No 10b5-1 plan is cited, but the filing still lacks context on why the director sold (tax, diversification, or scheduled program not disclosed here).

Relevance 6/10Novelty 6/10Timing: filed Oct 15, transaction dated Oct 14

Background

The filing is an SEC Form 4 insider transaction for Clear Channel Outdoor Holdings, Inc., reported by director Joe Marchese.

Company-level read

Ticker impact

$CCONeutralMedium confidence
Context

Clear Channel Outdoor director Joe Marchese sold 906,807 shares to the issuer for about $2.20M at $2.43/share, leaving 0 shares.

Expected impact

Likely modest sentiment drag as traders note the director exited the position, but impact should be limited because the filing is a routine Form 4 and the transaction is to the issuer.

Evidence & confidence

The article is a primary SEC Form 4 disclosure, but it is an insider sale with no accompanying guidance, deal, or operational change. The “sale to issuer” code D often aligns with issuer buyback mechanics, reducing interpretive weight.

Market effects

Minimal, as this is a single-company insider transaction with no stated operational or sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because the transaction is “sale to issuer” (code D), it may reflect routine buyback participation rather than a bearish view on fundamentals.

Key entities

  • Clear Channel Outdoor Holdings, Inc.

    Subject of the Form 4 insider transaction; director Joe Marchese sold shares to the issuer.

  • MARCHESE JOE

    Director who sold 906,807 shares at $2.43/share, total value about $2.20M, leaving 0 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

Cameco’s Westinghouse Stake Could Be Worth More Than $24.5 Billion

Cameco (CCO) shares rose 3.6% on reports that its co-owned Westinghouse is targeting a $50B US IPO, potentially valuing Cameco's 49% stake at over $24.5B. Cameco's Q2 earnings showed a Westinghouse net loss, but the company attributes this to project-related revenue fluctuations. Westinghouse's adjusted EBITDA fell to C$163M in Q2 from C$352M a year earlier. Cameco's P/E ratio has not significantly re-rated following the IPO news, with estimates ranging from $15B to $50B for Westinghouse.

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).